Skip to ContentSkip to Navigation
About us Latest news News News articles

Social stress in adolescent rats: adult behavioral and neurobiological consequences

07 September 2012

PhD ceremony: Mr. J. Vidal Mollon, 14.30 uur, Academiegebouw, Broerstraat 5, Groningen

Dissertation: Social stress in adolescent rats: adult behavioral and neurobiological consequences

Promotor(s): prof. J.M. Koolhaas

Faculty: Mathematics and Natural Sciences

The main aim of the thesis of Jose Vidal Mollon is to study the adult behavioral consequences of suffering from victimization during adolescence in rats and to establish an animal model to study which factors contribute to resistance and vulnerability to suffer from social stress. Adolescence has been described as an important period to acquire social competences required for adult life. It has been suggested that social stress experiences during adolescence could affect the development of the brain. These changes in the brain may be related with the development of certain psychopathologies such as depression and social anxiety. But some of the victims of social stress are resistant to the consequences of this type of stressors.

Last modified:13 March 2020 01.02 a.m.
Share this Facebook LinkedIn
View this page in: Nederlands

More news

  • 17 July 2025

    Veni-grants for eleven UG researchers

    The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to eleven researchers of the University of Groningen and the UMCG: Quentin Changeat, Wen Wu, Femke Cnossen, Stacey Copeland, Bart Danon, Gesa Kübek, Hannah Laurens, Adi...

  • 14 July 2025

    ERC Proof of Concept grant for Kottapalli and Covi

    Professors Ajay Kottapalli and Erika Covi have received Proof of Concept grants from the European Research Council (ERC).

  • 10 July 2025

    Dutch Research Agenda funding for nanomedicine research

    Prof Dr Anna Salvati, Dr Christoffer Åberg and Prof Dr Siewert-Jan Marrink have been granted a National Science Agenda (NWA) funding to further develop life-saving drugs based on nanotechnology with the NanoMedNL consortium.